Expression of a mutated form of the p85α regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO)

Leukemia

Volumn 16, Issue 5, 2002, Pages 894-901

  Jucker M ^a,b   Sudel K ^a   Horn, S ^a   Sickel, M ^b   Wegner, W ^a   Fiedler, W ^a   Feldman, R A ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Hodgkin's disease; Mutant; Phosphatidylinositol 3 kinase; SH2 domain

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN P85; PROTEIN SERINE THREONINE KINASE; PROTEIN SUBUNIT; WORTMANNIN;

APOPTOSIS; ARTICLE; CANCER PATIENT; CARBOXY TERMINAL SEQUENCE; CELL COUNT; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; FRAMESHIFT MUTATION; HEMATOPOIETIC CELL; HODGKIN DISEASE; HUMAN; HUMAN CELL; LEUKEMOGENESIS; LYMPHOMA CELL LINE; MOLECULAR CLONING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0036111802     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402484     Document Type: Article

References (64)

1. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease
2. Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease
3. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells
4. Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease
5. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus
6. Heterogeneous expression of proto-oncogenes in Hodgkin's disease derived cell lines
7. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines
8. Single cell analysis of Hodgkin and Reed-Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations
9. Phosphatidylinositol 3-kinase
10. Phosphatidylinositol 3-kinase a key enzyme in diverse signaling pathways
11. Agonist-stimulated synthesis of phosphatidylinositol(3, 4, 5)-trisphosphate: A new intracellular signaling system?
12. 3)/Tec kinase-dependent calcium signaling pathway: A target for SHIP-mediated inhibitory signals
13. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase akt through its pleckstrin homology domain
14. Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: Phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signaling between interleukin-3 and colony stimulating factor
15. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt
16. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B
17. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase
18. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region
19. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway
20. Phosphatidylinositol kinase activity associates with viral src protein
21. Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants
22. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor
23. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase
24. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases
25. A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo
26. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain
27. PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase
28. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors
29. SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors
30. Activation of phosphatidyl-inositol-3′ kinase by src family kinase SH3 binding to the p85 subunit
31. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase
32. Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo
33. Two neoplastic cell lines with unique features derived from Hodgkin's disease
34. Hodgkin's disease: Establishment and characterization of four in vitro cell lines
35. Characteristics of Hodgkin's disease-derived cell lines
36. Phenotypic analysis of an established cell line derived from a patient with Hodgkin's disease (HD)
37. Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Sternberg-Reed cells
38. Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease
39. Hodgkin's disease derived cell lines HDLM-2 and L-428: Comparison of morphology, immunological and isoenzyme profiles
40. A comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3-kinase
41. Determination of nucleotide sequences in DNA
42. The Inositol 5-phosphatase SHIP is expressed as 145 and 135 kD proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro
43. A tyrosine-phosphorylated protein of 140 kD is constitutively associated with the phosphotyrosine binding domain of Shc and the SH3 domains of Grb2 in acute myeloid leukemia cells
44. Ligand-dependent transformation by the receptor for human granulocyte/macrophage colony-stimulating factor and tyrosine phosphorylation of the receptor beta subunit
45. Identification of a new adaptor protein that may link the common β subunit of the receptor for granulocyte/macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 to phosphatidylinositol 3-kinase
46. Structural organization and alternative splicing of the murine phosphoinositide 3-kinase p85α gene
47. Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85
48. PI 3-kinase: Structural and functional analysis of intersubunit interactions
49. PI3K: Downstream AKTion blocks apoptosis
50. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/Akt: Involvement of MEK upstream of Bad phosphorylation
51. Akt/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation
52. Insulin-stimulated protein kinase B phosphorylation ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase
53. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides
54. Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo
55. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase
56. In vitro differentiation of a Hodgkin's disease derived cell line
57. SH2 domains recognize specific phosphopeptide sequences
58. A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor
59. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor β receptor
60. Modification of the 85-kilodalton subunit of phosphatidylinositol-3 kinase in platelet-derived growth factor-stimulated cells
61. Regulation of the p85/p110 phosphatidylinositol 3′-kinase: Stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit
62. Regulation of the p85/p110alpha phosphatidylinositol 3′-kinase
63. Production of monoclonal antibodies specific to the carboxyl terminal region of the 85 kDa subunit of phosphatidylinositol 3-kinase: Use of the antibodies in recognition of mutant p85
64. Chromosome 5